![Jie Deng, MD PhD Profile](https://pbs.twimg.com/profile_images/1795908694364090370/uXGyfMau_x96.jpg)
Jie Deng, MD PhD
@JieDengMDPhD
Followers
1K
Following
11K
Statuses
508
Asst Professor @UCLAHealth • Thoracic & GI • #RadOnc Physician-Scientist studying myeloid biology & immunotx • #doubledocs @Dartmouth
Los Angeles, CA
Joined December 2018
RT @Mat_Guc: Randomized comparison of SBRT vs RFA for recurrent small HCC (n=166 pts) - Freedom from local progression significantly improv…
0
40
0
One of the best teachers I’ve ever had, grateful to be your friend and colleague. All the best in your next chapter and we’ll miss you at UCLA @MinsongUC
Behind every great radiation oncologist is an even greater medical physicist. Your family at UCLA is going to miss you so much, Minsong!
1
2
24
Looking forward to this session by @TrudyWuMD and other UCLA colleagues
Join us for an engaging educational webinar, Liver Transplant for Cholangiocarcinoma, on December 12, 2024, at 4:00pm ET. Expert presenters from the multidisciplinary team at the University of California, Los Angeles (@UCLA) will explore the history and advancements of liver transplantation and its evolving role in treating #cholangiocarcinoma. This session is designed to help patients and their families better understand treatment options and the advanced, patient-centered approaches available at UCLA, a leading tertiary care center. Register now at
0
0
5
RT @DrewMoghanaki: The phase III KEYNOTE-867 study results will be presented this week at #ESMO24. The difference in G3 toxicity rates is i…
0
35
0
RT @DrewMoghanaki: The phase III CheckMate 73L study results will be presented this week at #ESMO24. Similar to PACIFIC-2, there is no sign…
0
24
0
RT @DrewMoghanaki: Absolutely brilliant video emphasizing how lung SBRT is truly painless. #radonc @shalinivinod13
0
9
0
RT @_ShankarSiva: 📣Really important data to consider when interpreting phase III trials #radonc - n=80,000+ patients, 52% permissive of of…
0
17
0
@DrHongchengZhu @IASLC @UCLAHealth @DrewMoghanaki Wonderful meeting you! Thanks for spending time with us and enjoyed learning about your work also.
0
0
2
RT @TeWilliamsMD: Nice to see our AFT-16 trial results published in @JAMAOnc. I think some of the best results seen in #radonc for Stage 3…
0
20
0
RT @ACKoongMDPhD: Congrats @ebludmir and @ChadTangMD! This @MDAndersonNews P2 randomized study shows PFS of 10.3 mo vs. 2.5 mo in #Pancrea…
0
41
0
RT @DrewMoghanaki: A multidisciplinary team at UCLA, including expertise from our Center for East-West Medicine, publishes a contemporary r…
0
10
0
RT @5_utr: 🚨 Notable-HCC Early stage resectable HCC Neoadjuvant PD-1 blockade plus SBRT -> surgery -> adjuvant ORR 63.2%, 100% DCR!🤩…
0
26
0
RT @MSteinbergMD: It’s our pleasure to announce the appointment of Dr. @TKaprealianMD as Vice Chair of Clinical Operations for the Departme…
0
4
0
RT @MSteinbergMD: It’s a pleasure to announce the appointment of Dr. @AmarUKishan to Executive Vice Chair for the Department of Radiation O…
0
10
0
RT @AngelaHong: Stellar presentation @DKirschMDPhD First trial on adding IO in #sarcoma #neoadjuvant #adjuavnt pembrolizumab to preop RT a…
0
13
0